se of the Cyclops® by Parkinson’s patients
- Conditions
- Parkinson's disease
- Registration Number
- NL-OMON22676
- Lead Sponsor
- Martini Hospital Groningen
- Brief Summary
Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods? Luinstra M, Rutgers AW, Dijkstra H, Grasmeijer F, Hagedoorn P, Vogelzang JM, Frijlink HW, de Boer AH. PLoS One. 2015 Jul 14;10(7):e0132714.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Diagnosed with Parkinson's disease by a nerologist;
- At least 18 years of age;
- Signed informed consent.
Exclusion Criteria
- Not able to understand inhalation instruction (within a maximum of 30 minuten).
- Previously participated in the Parkinson DPI-1, DPI-2 or DPI-3 studie (prior knowledge of the inhalation
maneuver);
- Active pulmonary disease.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The main study parameter is to investigate whether Parkinson’s patients are able to reproduce an optimal inhalation technique for the Cyclops® inhaler by measuring the pressure drop (kPa), breath hold time (sec.) and inhaled volume (L) after first and second inhalation instruction.
- Secondary Outcome Measures
Name Time Method The secondary study parameter is to investigate whether Parkinson’s patients perform the correct steps in accordance with the patient instruction card with the Cyclops® inhaler after first and second inhalation instruction.